Cardiff Oncology Inc (CRDF)

SG&A Expenses

$16.82M

TTM · Period ending: · USD

CRDF logo

CRDF SG&A Expenses

Latest reported$16.82M
CRDF TTM SG&A Expenses ($2.84M → $16.82M)
High-resolution chart · PNG

CRDF sg&a expenses history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Cardiff Oncology Inc SG&A Expenses — Trailing twelve months (TTM) (USD)
Period endingSG&A Expenses (USD)
16,822,000
13,018,000
10,906,000
10,922,000
7,025,000
10,240,000
9,254,000
8,968,000
11,907,000
12,988,000
13,043,000
13,396,000
13,534,000
12,324,000
13,181,000
13,938,000
13,791,000
13,543,000
11,838,000
11,420,014
10,134,014
8,965,014
8,216,014
2,072,910
3,309,588
3,168,588
3,157,588
7,568,678
6,353,200
6,976,071
8,006,048
8,195,048
10,609,362
13,132,643
14,232,290
17,046,290
18,618,420
19,542,036
22,999,211
22,410,211
20,505,376
18,825,608
14,364,447
12,975,447
11,235,814
9,217,867
8,545,299
7,445,565
7,644,341
7,223,551
7,002,198
6,394,932
4,928,022
4,258,627
3,378,874
2,978,387
2,825,575
2,599,732
2,323,812
3,171,299
5,855,069
5,751,044
5,640,000
4,190,000
920,000
440,000
627,634
1,610,531
2,185,814
2,837,509
2,209,875
1,226,978
651,695
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.